FIELD: medicine; pharmacology.
SUBSTANCE: invention relates to therapeutic or prophylactic means against inflammation and dysfunction of neural system, which inhibits expression of cytokines and chemokines associated genes, increases viability of neural cells, enhances synaptic transmission and protects synapses, as well as treatment method for nervous system dysfunction. Active ingredient of the means is hyaluronane tetrasaccharide HA4, consisting of two members; the structure unit being D-glucuronic acid - β-1,3-D-N-acetylglucosamine-β-1,4-.
EFFECT: effective preventing and treatment for inflammatory diseases of nervous system.
23 cl, 6 ex, 6 tbl, 18 dwg
Authors
Dates
2008-12-27—Published
2006-09-25—Filed